New International Research Survey from Boston Children's Hospital Recruiting participants for an anonymous online survey to explore the symptoms and impact of musculoskeletal pain in Noonan syndrome for adolescents and…

BioMarin has made the decision to discontinue development of VOXZOGO® (vosoritide) for children with Noonan syndrome. Read the press release here.

Restoring the brake: Using molecular glues to fix a broken CRAF off-switch in Noonan Syndrome   Another RAS Dialogue Blog post has dropped from the NCI Frederick National Lab RAS…